Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease cardiogenic shock
Comorbidity C0027051|myocardial infarction
Sentences 146
PubMedID- 22431494 Patients in a variety of cardiovascular disease states may benefit from temporary percutaneous cardiac support, including those in acute decompensated heart failure, fulminant myocarditis, acute myocardial infarction with or without cardiogenic shock and those undergoing high-risk percutaneous coronary intervention.
PubMedID- 23472937 Conclusions: the use of iabp counterpulsation did not significantly reduce 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock for whom an early revascularization strategy was planned.
PubMedID- 21132310 Patients presenting with cardiogenic shock because of acute myocardial infarction were subjected to standard care with primary pci and intra-aortic balloon pump (iabp).
PubMedID- 23265097 Background: sex differences in the management of acute myocardial infarction (ami) patients with cardiogenic shock (cs) have not been well studied.
PubMedID- 25976448 However, its impact on on-treatment platelet reactivity and clinical outcome in patients with acute myocardial infarction (ami) complicated by cardiogenic shock and undergoing pci with p2y12 receptor inhibitor treatment is less clear.
PubMedID- 26048389 Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.
PubMedID- 22739496 Objectives: acute st elevation myocardial infarction (stemi) presenting with cardiogenic shock (cs) is associated with dismal prognosis.
PubMedID- 23441474 The terminal cardiogenic shock was associated with myocardial infarction.
PubMedID- 23096512 [clinical characteristics, management and prognostic evolution of patients admitted within six hours of symptom onset with st-segment elevation acute myocardial infarction complicated by cardiogenic shock : twenty year monocentric study].
PubMedID- 22062683 Background: the effectiveness of pcps for acute myocardial infarction (ami) complicated with cardiogenic shock has been reported, but there are few reports on the use of pcps for massive pe with circulatory collapse.
PubMedID- 26453047 cardiogenic shock resulted from acute myocardial infarction in 17 patients (43 %), dilated cardiomyopathy in 12 (30 %) and postcardiotomy cardiac failure in 7 (18 %).
PubMedID- 22569335 Although recent meta-analyses challenge current aha/acc/esc guidelines, adequately powered randomized studies are needed to elucidate the role of iabp in patients with acute myocardial infarction complicated by cardiogenic shock.
PubMedID- 22437987 We report the first case in which the impella 5.0 device was placed directly into the ascending aorta via a small right anterior thoracotomy in a patient following acute myocardial infarction complicated by cardiogenic shock.
PubMedID- 26054832 Device therapy: where next in cardiogenic shock owing to myocardial infarction.
PubMedID- 24494769 This article presents a case study involving a man with acute myocardial infarction complicated by cardiogenic shock and pulmonary oedema.
PubMedID- 24075314 Aim: to assess the impact on in-hospital and long-term survival of thrombus aspiration (ta) during primary percutaneous coronary intervention (ppci) for st-segment elevation myocardial infarction (stemi) complicated by cardiogenic shock (cs).
PubMedID- 25855797 Culprit or multivessel revascularisation in st-elevation myocardial infarction with cardiogenic shock.
PubMedID- 22847042 Efficacy and timing of intra-aortic counterpulsation in patients with st-elevation myocardial infarction complicated by cardiogenic shock.
PubMedID- 23147461 Drug-eluting stents should not be used in st-elevated myocardial infarction with cardiogenic shock.
PubMedID- 25260401 The aim of this study was to explore myocardial protection of early extracorporeal membrane oxygenation (ecmo) support for acute myocardial infarction with cardiogenic shock in pigs.
PubMedID- 24462137 Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock.
PubMedID- 24954319 Purpose: limited data are available on the role of percutaneous cardiopulmonary support (pcps) for the treatment of acute myocardial infarction (ami) patients with cardiogenic shock.
PubMedID- 23468450 A 34-year-old male patient was referred for primary percutaneous coronary intervention for st-segment elevation myocardial infarction with cardiogenic shock and was found to have embolic left coronary artery occlusion and subsegmental pulmonary artery emboli as a consequence of venous thrombosis to trauma to the thigh in the presence of a patent foramen ovale.
PubMedID- 22787475 However, cardiogenic shock with myocardial infarction resulting from simultaneous multiple coronary artery spasm has been rarely reported, and not in korea.
PubMedID- 26373810 Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: evidence from the portuguese nationwide registry.
PubMedID- 21829053 Material and methods: the course of acute myocardial infarction complicated by cardiogenic shock in patients with aortic counterpulsation was analyzed.
PubMedID- 25170414 We report the first case of spontaneous multivessel spasm in a male patient with bronchial asthma of arab ethnicity resulting in acute myocardial infarction complicated by cardiogenic shock, recurrent ventricular arrhythmias, and transient complete heart block.
PubMedID- 21764661 Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the euro heart survey on pci.
PubMedID- 23940425 Background: the clinical outcome of patients with myocardial infarction (mi) complicated by cardiogenic shock (cs) who require mechanical ventilation (mv) is poor.
PubMedID- 24133510 Elderly patients are considered to be at high risk for acute myocardial infarction (ami) complicated by cardiogenic shock (cs).
PubMedID- 22263168 Results of extracorporeal membrane oxygenation (ecmo) support before coronary reperfusion in cardiogenic shock with acute myocardial infarction.
PubMedID- 19789449 Acute kidney injury in st-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission.
PubMedID- 25637294 Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the iabp-shock ii-trial.
PubMedID- 24364017 [71] evaluated right ventricular function in 25 consecutive acute myocardial infarction patients with cardiogenic shock not responding sufficiently to conventional treatment.
PubMedID- 22709745 Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial.
PubMedID- 20662231 We experienced a case of acute myocardial infarction (ami) with cardiogenic shock due to compression of the left main trunk (lmt) by a false lumen of an aad.
PubMedID- 22591567 Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock.
PubMedID- 20829210 Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock.
PubMedID- 24362653 myocardial infarction complicated with cardiogenic shock had very high mortality (83.33%).
PubMedID- 25830921 Unverzagt s, machemermt, solms a, thiele h, burkhoff d, seyfarthm, dewaha a, ohman em, buerke m, haerting j, werdan k, prondzinsky r. intra-aortic balloon pump counterpulsation (iabp) for myocardial infarction complicated by cardiogenic shock.
PubMedID- 19770739 Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized iabp shock trial for attenuation of multiorgan dysfunction syndrome.
PubMedID- 22767014 The successful combined use of impella lp 2.5 and intra-aortic balloon pump in st-elevation myocardial infarction with refractory cardiogenic shock.
PubMedID- 25984680 However, current literature demonstrated significantly varied indications for iabp application and prognosis.the objective of the study was to assess the potential benefits or risks of iabp treatment for acute myocardial infarction (ami) complicated with or without cardiogenic shock.medline and embase database were systematically searched until november 2014, using the terms as follows: iabp, iabc (intra-aortic balloon counterpulsation), ami, heart infarction, coronary artery disease, ischemic heart disease, and acute coronary syndrome.
PubMedID- 22322287 Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock.
PubMedID- 24077607 Recent findings: there have been decades of nonrandomized and observational data available, but only in the last 3 years has there been availability of randomized evidence for iabp use in acute myocardial infarction (ami) with cardiogenic shock, st elevation acute coronary syndromes (ste-acs) without shock and high-risk percutaneous coronary intervention (pci) cohorts.
PubMedID- 21226896 Hypertensive crisis may develop in some patients resulting in cardiovascular shock with stroke, myocardial infarction, or multiple organ failure [5,6].
PubMedID- 22913597 Acute left main occlusion is a rare but devastating presentation of myocardial infarction, invariably with cardiogenic shock.
PubMedID- 24848410 Recent findings: recently published randomized controlled trials (rcts) and meta-analyses have demonstrated acceptable safety for iabp but have raised doubt over efficacy in acute myocardial infarction (mi) both with and without cardiogenic shock.
PubMedID- 20690098 Intra-aortic balloon pumps (iabp) are commonly used in the setting of an acute myocardial infarction that is complicated by cardiogenic shock or mechanical complications such as a ventricular septal defect or papillary muscle rupture.
PubMedID- 25965624 Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the iabp-shock ii-trial.

Page: 1 2 3